Codexis Share Price (NASDAQ: CDXS)

$2.73

▲

0.01

(0.37%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Codexis Stock chart to analyse performance

Codexis stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$2.67
Today's High:$2.73
$2.73
2.38%
Downside
Day's Volatility :2.38%
Upside
0.0%
52 Weeks Low:$1.90
52 Weeks High:$6.08
$2.73
30.4%
Downside
52 Weeks Volatility :68.75%
Upside
55.1%

Codexis Stock Returns

Period	Codexis, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	21.56%	3.6%	0.0%
6 Months	0.0%	-7.7%	0.0%
1 Year	-4.04%	-12.6%	0.0%
3 Years	-60.53%	10.2%	-4.1%

Codexis, Inc. Key Stats

Check Codexis key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.72
Open	$2.71
Today's High	$2.73
Today's Low	$2.665
Market Capitalization	$245.5M
Today's Volume	$514.4K
52 Week High	$6.08
52 Week Low	$1.9
Revenue TTM	$57.2M
EBITDA	$-52.3M
Earnings Per Share (EPS)	$-0.8
Profit Margin	-113.67%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-111.0%

Stock Returns calculator for Codexis Stock including INR - Dollar returns

The Codexis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Codexis investment value today

Current value as on today

₹1,01,074

Returns

₹1,074

(+1.07%)

Returns from Codexis Stock

₹4,211 (-4.21%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Codexis Stock

22%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Codexis Stock from India on INDmoney has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Codexis, Inc.

Name
Holdings %
Name
Holdings %
Opaleye Management Inc
13.96%
BlackRock Inc
8.40%
Casdin Capital, LLC
7.98%
Vanguard Group Inc
5.08%
FMR Inc
5.06%
Aberdeen Group PLC
4.65%

Analyst Recommendation on Codexis Stock

Rating

Trend

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Codexis(by analysts ranked 0 to 5 stars)

Codexis Share Price Target

What analysts predicted

Upside of 159.46%

Target:

$7.08

Current:

$2.73

Codexis share price target is $7.08, a slight Upside of 159.46% compared to current price of $2.73 as per analysts' prediction.

Codexis Stock Insights

Price Movement
In the last 7 days, CDXS stock has moved down by -5.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 7.54M → 15.32M (in $), with an average increase of 50.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -20.68M → -13.27M (in $), with an average increase of 55.9% per quarter
CDXS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 75.3%
CDXS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 177.0%
Price to Sales
ForCDXS every $1 of sales, investors are willing to pay $3.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Codexis, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$68.5M	↑ 12.98%
Net Income	$-11.9M	↑ 9.72%
Net Profit Margin	-17.43%	↑ 0.52%

	FY20	Y/Y Change
Revenue	$69.1M	↑ 0.87%
Net Income	$-24.0M	↑ 101.17%
Net Profit Margin	-34.77%	↓ 17.34%

	FY21	Y/Y Change
Revenue	$104.8M	↑ 51.69%
Net Income	$-21.3M	↓ 11.37%
Net Profit Margin	-20.31%	↑ 14.46%

	FY22	Y/Y Change
Revenue	$138.6M	↑ 32.3%
Net Income	$-33.6M	↑ 57.86%
Net Profit Margin	-24.24%	↓ 3.93%

	FY23	Y/Y Change
Revenue	$70.1M	↓ 49.39%
Net Income	$-76.2M	↑ 126.96%
Net Profit Margin	-108.69%	↓ 84.45%

	FY24	Y/Y Change
Revenue	$59.3M	↓ 15.39%
Net Income	$-65.3M	↓ 14.38%
Net Profit Margin	-109.99%	↓ 1.3%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$17.1M	↓ 35.72%
Net Income	$-11.5M	↑ 59.97%
Net Profit Margin	-67.39%	↓ 40.31%

	Q2 FY24	Q/Q Change
Revenue	$8.0M	↓ 53.27%
Net Income	$-22.8M	↑ 97.78%
Net Profit Margin	-285.19%	↓ 217.8%

	Q3 FY24	Q/Q Change
Revenue	$12.8M	↑ 60.83%
Net Income	$-20.6M	↓ 9.29%
Net Profit Margin	-160.84%	↑ 124.35%

	Q4 FY24	Q/Q Change
Revenue	$21.5M	↑ 67.23%
Net Income	$-10.4M	↓ 49.73%
Net Profit Margin	-48.35%	↑ 112.49%

	Q1 FY25	Q/Q Change
Revenue	$7.5M	↓ 64.85%
Net Income	$-20.7M	↑ 99.38%
Net Profit Margin	-274.27%	↓ 225.92%

	Q2 FY25	Q/Q Change
Revenue	$15.3M	↑ 103.21%
Net Income	$-13.3M	↓ 35.85%
Net Profit Margin	-86.59%	↑ 187.68%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$52.8M	↑ 10.11%

	FY20	Y/Y Change
Profit	$55.3M	↑ 4.71%

	FY21	Y/Y Change
Profit	$82.5M	↑ 49.23%

	FY22	Y/Y Change
Profit	$100.6M	↑ 21.82%

	FY23	Y/Y Change
Profit	$57.3M	↓ 42.98%

	FY24	Y/Y Change
Profit	$43.1M	↓ 24.9%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$11.0M	↓ 51.23%

	Q2 FY24	Q/Q Change
Profit	$3.3M	↓ 70.11%

	Q3 FY24	Q/Q Change
Profit	$8.5M	↑ 159.79%

	Q4 FY24	Q/Q Change
Profit	$17.8M	↑ 109.09%

	Q1 FY25	Q/Q Change
Profit	$4.8M	↓ 72.98%

	Q2 FY25	Q/Q Change
Profit	$13.2M	↑ 174.99%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-12.6M	↓ 10.88%
Investing Cash Flow	$-3.7M	↑ 32.5%
Financing Cash Flow	$54.0M	↑ 39.91%

	FY20	Y/Y Change
Operating Cash Flow	$-16.5M	↑ 31.08%
Investing Cash Flow	$-5.7M	↑ 56.83%
Financing Cash Flow	$80.8M	↑ 49.75%

	FY21	Y/Y Change
Operating Cash Flow	$-14.3M	↓ 13.34%
Investing Cash Flow	$-21.4M	↑ 272.69%
Financing Cash Flow	$3.8M	↓ 95.34%

	FY22	Y/Y Change
Operating Cash Flow	$11.3M	↓ 179.09%
Investing Cash Flow	$-13.6M	↓ 36.62%
Financing Cash Flow	$-575.0K	↓ 115.26%

	FY23	Y/Y Change
Operating Cash Flow	$-52.6M	↓ 566.48%
Investing Cash Flow	$-4.9M	↓ 64.22%
Financing Cash Flow	$8.2M	↓ 1520.35%

	FY24	Y/Y Change
Operating Cash Flow	$-49.4M	↓ 6.13%
Investing Cash Flow	$-57.0M	↑ 1072.91%
Financing Cash Flow	$60.5M	↑ 641.06%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-7.8M	↓ 29.43%
Investing Cash Flow	$-28.6M	↓ 2687.23%
Financing Cash Flow	$29.3M	-

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-12.2M	↑ 56.22%
Investing Cash Flow	$-27.1M	↓ 5.17%
Financing Cash Flow	$-197.0K	↓ 100.67%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-13.0M	↑ 6.71%
Investing Cash Flow	$1.5M	↓ 105.66%
Financing Cash Flow	$30.3M	↓ 15483.76%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-16.5M	↑ 26.82%
Investing Cash Flow	$-2.9M	↓ 286.76%
Financing Cash Flow	$1.1M	↓ 96.26%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-13.8M	↓ 16.21%
Investing Cash Flow	$11.8M	↓ 511.07%
Financing Cash Flow	$1.1M	↓ 4.15%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-18.0M	↑ 30.21%
Investing Cash Flow	$-367.0K	↓ 103.12%
Financing Cash Flow	$26.8M	↑ 2367.65%

Codexis Technicals Summary

Sell

Neutral

Buy

Codexis is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Codexis, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Codexis, Inc.	2.05%	0.0%	-4.04%	-60.53%	-80.05%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Codexis, Inc.	NA	NA	-1.16	-0.6	-1.11	-0.26	NA	0.62
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Codexis, Inc.	Buy	$245.5M	-80.05%	NA	-113.67%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Codexis, Inc.

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Organization	Codexis
Employees	188
CEO	Dr. Stephen George Dilly MBBS, Ph.D.
Industry	Process Industries

Key Management of Codexis, Inc.

Name	Title
Dr. Stephen George Dilly MBBS, Ph.D.	President, CEO & Chairman
Ms. Georgia L. Erbez	Chief Financial Officer
Mr. Kevin Norrett M.B.A., M.S.	Chief Operating Officer
Dr. Alison Moore Ph.D.	CTO & Executive VP
Senator Byron L. Dorgan M.B.A.	Consultant
Ms. Carrie McKim	Director of Investor Relations
Ms. Karen Frechou-Armijo	Senior VP & Head of Human Resources
Dr. Stefan Lutz Ph.D.	Senior Vice President of Research
Mr. John Schiffhauer	Senior Vice President of Intellectual Property

Important FAQs about investing in CDXS Stock from India :

What is Codexis share price today?

Codexis share price today is $2.73 as on August 30, 2025 at 1:29 am IST at the close of the market. Codexis share today touched a day high of $2.73 and a low of $2.67.

What is the 52 week high and 52 week low for Codexis share?

Codexis share touched a 52 week high of $6.08 and a 52 week low of $1.90. Codexis stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $2.73, lower by 55.1% versus the 52 week high.

How to invest in Codexis Stock (CDXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Codexis on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Codexis Shares that will get you 0.5495 shares as per Codexis share price of $2.73 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Codexis Stock (CDXS) from India?

Indian investors can start investing in Codexis (CDXS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Codexis stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Codexis share’s latest price of $2.73 as on August 30, 2025 at 1:29 am IST, you will get 3.6630 shares of Codexis. Learn more about fractional shares .

What are the returns that Codexis has given to Indian investors in the last 5 years?

Codexis stock has given -80.05% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?